Dapabite M 10/500 mg Tablet (10 Tab)

Dapabite M 10/500 Tablet Overview:

Dapabite M 10/500 Tablet is a combination anti-diabetic medicine used to treat type 2 diabetes mellitus in adults. It contains Dapagliflozin and Metformin, which work together to effectively control high blood sugar levels. This dual-action medicine is usually prescribed when lifestyle changes such as diet and exercise, or treatment with a single anti-diabetic medicine, are not sufficient to manage blood glucose levels.

Dapabite M works by improving the body’s response to insulin, reducing excess sugar production in the liver, and removing extra glucose from the body through urine. These combined actions help maintain better blood sugar control throughout the day.

Uncontrolled type 2 diabetes can lead to serious health complications such as heart disease (including heart attack and stroke), kidney damage, nerve problems, vision issues, and delayed wound healing. By keeping blood sugar levels under control, Dapabite M helps reduce the risk of these long-term complications.

It is important to note that Dapabite M 10/500 Tablet is not for treating Type 1 diabetes or diabetic ketoacidosis.

Composition:

Each film-coated bilayered tablet contains- Dapagliflozin Propanediol Monohydrate Eqv. To Dapagliflozin: 10 mg, Metformin Hydrochloride (As Extended Release): 500 mg and Excipients q.s.

Colour: Ferric Oxide Red (In Dapagliflozin Layer)

Uses & Benefits of Dapabite M 10/500 Tablet:

Dapabite M 10/500 Tablet is used for the treatment of Type 2 diabetes mellitus or non-insulin-dependent diabetes mellitus (NIDDM).

How Dapabite M 10/500 Tablet Works:

Dapabite M 10/500 Tablet works through dual mechanisms: reducing glucose production in the liver, increasing glucose excretion in the urine, and improving insulin sensitivity in the body.

Dapagliflozin blocks SGLT2 receptors in the kidneys, preventing glucose reabsorption and allowing excess sugar to be eliminated through urine. This process is insulin-independent, making it effective even in insulin-resistant conditions.

Metformin primarily works by suppressing hepatic glucose production and enhancing peripheral glucose uptake by improving insulin sensitivity. The combination provides complementary actions that result in more comprehensive glucose control than either medication alone.

Dosage of Dapabite M 10/500 Tablet:

• Usage Directions

Take Dapabite M 10/500 Tablet exactly as prescribed by your doctor, and follow the recommended dosage and schedule. Dapabite M 10/500 Tablet should be swallowed as a whole without crushing, chewing, or breaking it, and ideally at the same time each day. Do not stop or alter the dose of Dapabite M 10/500 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. Ask your doctor or pharmacist to explain any administration procedure you do not understand.

• Missed Dose

If you miss a dose of Dapabite M 10/500 Tablet, take it as soon as it is remembered. If it is time for your next dose of Dapabite M 10/500 Tablet, skip the missed dose and resume your regular schedule. Do not double the dose to make up for the missed dose. Discuss missed dose management strategies with your healthcare provider, especially if you miss doses regularly. You can set reminders on your smartphone, keep drug organizer boxes, or use other audio-visual technologies to prevent missing a dose.

• Overdose

Overdose of Dapabite M 10/500 Tablet can be serious and requires immediate medical attention. Signs of overdose may include severe hypoglycemia, lactic acidosis from the metformin component, excessive urination, dehydration, and electrolyte imbalances. If overdose is suspected, contact emergency medical services immediately or go to the nearest hospital.

Contraindications of Dapabite M 10/500 Tablet:

Dapabite M 10/500 Tablet is contraindicated in patients with acute renal failure or history of lactic acidosis. The medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney disease. Patients with active liver disease or alcoholism should avoid this medication due to the increased risk of lactic acidosis. The medication is not recommended during pregnancy or breastfeeding. Patients with severe heart failure requiring hospitalization should not use this medication. Hypersensitivity to dapagliflozin, metformin, or any component of the formulation is also a contraindication. Patients scheduled for surgery or imaging procedures requiring contrast agents may need temporary discontinuation.

Precautions & Warnings of Dapabite M 10/500 Tablet:

Several important precautions must be observed while using Dapabite M 10/500 Tablet. Elderly patients require special caution as they are more likely to have kidney, liver, or heart problems, which may require dose adjustments. Regular monitoring of kidney function is essential, as both components can affect renal function. Patients should be alert for signs of urinary tract infections and genital infections, which are more common with SGLT2 inhibitors. Dehydration risk is increased, particularly in elderly patients or those taking diuretics. Blood sugar can go too low when combined with other diabetes medications, including insulin or sulfonylureas. Alcohol consumption should be limited or avoided as it can alter glycemic control and increase toxicity. Patients should be educated about recognizing signs of lactic acidosis.

Side Effects of Dapabite M 10/500 Tablet:

Common side effects of Dapabite M 10/500 Tablet include urinary tract infections, genital yeast infections, increased urination, and mild gastrointestinal symptoms such as nausea, vomiting, or diarrhea. Hypoglycemia (low blood sugar) can occur, especially when used with other diabetes medications. Some patients may experience dizziness, headache, or fatigue during initial treatment. Serious but rare side effects include lactic acidosis, which presents with muscle pain, breathing difficulties, stomach pain, and weakness. Diabetic ketoacidosis, though uncommon, can occur and requires immediate medical attention. Dehydration and electrolyte imbalances may occur due to increased urination. Any persistent or severe side effects should be reported to healthcare providers immediately for proper evaluation and management.

Safety Related Advices of Dapabite M 10/500 Tablet:

• Pregnancy

Dapabite M 10/500 Tablet should be avoided during pregnancy. There are no adequate studies in women for determining infant risk when using this medication during pregnancy. The medication crosses the placental barrier and may affect fetal development. If pregnancy occurs during treatment, the medication should be discontinued immediately and safer alternatives should be used under medical supervision.

• Breastfeeding

Breastfeeding mothers are advised to avoid Dapabite M 10/500 Tablet as it may pass through breast milk and can cause side effects in breastfed babies. Therefore, it is important to consult your doctor before taking Dapabite M 10/500 Tablet while breastfeeding.

Alternative diabetes medications with better safety profiles during lactation should be considered whenever possible.

• Alcohol

Alcohol consumption should be limited or avoided while taking Dapabite M 10/500 Tablet, as excessive alcohol consumption can alter glycemic control and increase the risk of side effects. Alcohol can increase the risk of lactic acidosis, particularly due to the metformin component. It can also cause unpredictable changes in blood sugar levels, leading to either hypoglycemia or hyperglycemia. Patients who consume alcohol should monitor blood sugar levels more frequently and be aware of symptoms of lactic acidosis. If alcohol consumption is unavoidable, it should be done in moderation and with food. Healthcare providers should be informed about alcohol consumption patterns to adjust treatment accordingly.

• Using Machinery & Driving

Dapabite M 10/500 Tablet may affect the ability to drive or operate machinery, particularly during initial treatment or dose adjustments. The risk of hypoglycemia, especially when combined with other diabetes medications, can cause dizziness, confusion, or weakness that impairs judgment and reaction time. Patients should be cautious when driving until they understand how the medication affects them individually. Blood sugar should be well-controlled before engaging in activities requiring alertness and coordination. If experiencing symptoms of low blood sugar, patients should stop driving immediately and treat the hypoglycemia. Regular blood sugar monitoring before driving is recommended, particularly for patients on multiple diabetes medications.

• Food Interactions

Dapabite M 10/500 Tablet can be taken with or without food, as food does not significantly affect its absorption. However, taking the medication with meals may help reduce gastrointestinal side effects associated with metformin. Patients should maintain consistent dietary habits and follow their prescribed diabetic diet plan. High-fiber foods may slow the absorption of metformin but do not significantly impact its effectiveness. Avoiding excessive simple carbohydrates helps optimize the medication's glucose-lowering effects. Adequate hydration is important, especially since SGLT2 inhibitors increase urination. Patients should discuss any significant dietary changes with their healthcare provider to ensure optimal medication effectiveness.

• Drug Interactions

Dapabite M 10/500 Tablet can interact with several other medicines, so caution is important. Using it along with insulin or sulfonylureas (such as gliclazide) may increase the risk of low blood sugar (hypoglycemia). Diuretics can raise the chances of dehydration and may affect kidney function.

Special care is needed when undergoing imaging procedures that use contrast dyes, as these can increase the risk of sudden kidney problems. In such cases, the medicine may need to be stopped temporarily—usually 48 hours before and after the procedure—based on medical advice.

Since SGLT2 inhibitors like dapagliflozin can slightly lower blood pressure, monitoring may be required when taken with antihypertensive medicines. Some antibiotics and antifungal drugs may also interact with metformin and affect its action.

It is important to inform your doctor about all the medicines you are taking, including over-the-counter drugs and supplements, before starting or stopping any treatment.

Storage Instructions:

Store below 30°C. Protect from light and moisture. Keep out of reach of children. Dispose of expired or unneeded medications properly through local regulations or pharmacy take-back programs. Check expiration dates regularly and never use expired medication, as potency may decrease or safety may be compromised.

Additional Note:

• Monitor blood sugar, urine tests, cholesterol, and HbA1c regularly.
• Follow a healthy diet, exercise daily, and maintain a healthy weight.
• Carry quick sugar sources in case of low blood sugar.
• Attend all medical appointments and complete recommended lab tests.

Related Blood Glucose Monitors:

To manage diabetes at home, discover our simple, reliable home-use Blood Glucose Monitoring systems with Test Strips. Check Out

Frequently Asked Questions (FAQ)

Q: Can I stop taking Dapabite M 10/500 Tablet if my blood sugar levels normalize?

A: No, you should never stop taking Dapabite M 10/500 Tablet without consulting your healthcare provider, even if your blood sugar levels improve significantly. Diabetes is a chronic condition requiring ongoing management, and stopping medication abruptly can cause dangerous spikes in blood sugar levels that may lead to serious complications.

Q: What should I do if I experience frequent urination after starting Dapabite M 10/500 Tablet?

A: Increased urination is a common and expected effect of dapagliflozin, as it works by removing excess glucose through urine, but if it becomes severe or is accompanied by signs of dehydration, dizziness, or persistent thirst, contact your healthcare provider. Staying adequately hydrated and monitoring for signs of urinary tract infections is important during treatment.

Q: Is it safe to take Dapabite M 10/500 Tablet with my blood pressure medications?

A: Many patients safely take Dapabite M 10/500 Tablet with blood pressure medications, but close monitoring is necessary as the combination may enhance blood pressure-lowering effects and require dose adjustments. Always inform all your healthcare providers about every medication you're taking, including over-the-counter drugs and supplements, to prevent potentially dangerous interactions.

Q: What are the warning signs that I should seek immediate medical attention while taking Dapabite M 10/500 Tablet?

A: Seek immediate medical help if you experience symptoms of lactic acidosis (unusual muscle pain, trouble breathing, stomach pain, dizziness, feeling cold, or slow heart rate), severe dehydration, signs of diabetic ketoacidosis (nausea, vomiting, stomach pain, confusion, unusual drowsiness), or severe hypoglycemia (extreme weakness, confusion, trembling, or loss of consciousness). These conditions require emergency treatment and can be life-threatening if left untreated.

Reference:

1. XIGDUO XR (dapagliflozin and metformin HCl extended-release). Last Revised: July 2017. Accessed On: 31st March 2026. Click Here

2. XigDuo® 5 mg/1000 mg. Dapagliflozin/Metformin immediate-release Tablets Abbreviated Prescribing Information. Last Revised: 14th August 2018. Accessed On: 31st March 2026. Click Here

3. Dapagliflozin/Metformin Krka 5 mg/850 mg film-coated tablets. Dapagliflozin/Metformin Krka 5 mg/1 000 mg film-coated tablets. Accessed On: 31st March 2026. Click Here